Iovance Biotherapeutics

-$1.02 (-3.69%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IOVA and other ETFs, options, and stocks.

About IOVA

Iovance Biotherapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of cell therapies as novel cancer immunotherapy products. Its lead product candidate, LN-144 for metastatic melanoma, is an autologous adoptive cell therapy utilizing tumor-infiltrating lymphocytes (TIL), which are T cells derived from patients' tumors.

CEO
Frederick G. Vogt
Employees
241
Headquarters
San Carlos, California
Founded
2007

IOVA Key Statistics

Market Cap
4.13B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.17M
High Today
$27.94
Low Today
$26.52
Open Price
$27.72
Volume
856.45K
52 Week High
$54.21
52 Week Low
$15.88

IOVA Earnings

-$0.55
-$0.37
-$0.18
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure